Psoriasis therapeutics Market: Global Industry Analysis, Trends, Market Size and Forecasts up to 2023


Select Your License Type


samplerequest
makeanenquiry
download
Discount


The report on global psoriasis therapeutics market is an in depth analysis of the segments and sub-segments in the psoriasis therapeutics market .The report provides analysis for the global as well as regional markets over the period of 2015 to 2023. According to report the global psoriasis therapeutics market is expected to grow at a CAGR of 9.7% over the forecast period of 2017 - 2023.


Figure 1: Global Psoriasis therapeutics market by value 2017 - 2023


Psoriasis therapeutics Market

 

Segments Covered

The report on global psoriasis therapeutics market covers segments such as molecule, route of administration, dosage forms, and mechanism of action. The molecule segments include biologics, and small molecules. On the basis of route of administration the global psoriasis therapeutics market is categorized into oral, parenteral, and, topical.

 

Geographic Coverage

The report provides regional analysis covering geographies such as North America, Europe, Asia-Pacific, and Rest of the World. In this section the key trends and market size for each geography is provided over the period of 2015 – 2023.


Figure 2: Global Psoriasis Therapeutics Market by region, CAGR %, 2017-2023


Psoriasis therapeutics Market

 


The countries covered in the North America region include the U.S., Canada, and Mexico; while Asia-Pacific includes China, Japan, India, South Korea, Malaysia, and among others. Moreover, Germany, U.K., France, Spain, and Rest of Europe are included in the European region. The U.S. drives the growth in the North America region as it is the largest market in the region. The Asia-pacific region offers a substantial potential for the market growth owing to rapid growth in markets such as India and China. The APAC region is projected to experience a growth at a CAGR of x.x% over the period of 2017 - 2023.

 

Companies Profiled:

The report provides profiles of the companies in the global Psoriasis therapeutics market such as, Amgen, Inc., Johnson & Johnson, Eli Lilly and Company, AstraZeneca, Novartis AG, AbbVie Inc., and Celgene Corporation.

 

Report Highlights:

 The report provides deep insights on demand forecasts, market trends and micro and macro indicators. In addition, this report provides insights on the factors that are driving and restraining the global psoriasis therapeutics market. Moreover, IGR-Growth Matrix analysis given in the report brings an insight on the investment areas that existing or new market players can consider. 

The report provides insights into the market using analytical tools such as Porter’s five forces analysis and DRO analysis of psoriasis therapeutics market. Moreover, the study highlights current market trends and provides forecast from 2017 to 2023. We also have highlighted future trends in the psoriasis therapeutics Market that will impact the demand during the forecast period. Moreover, the competitive analysis given in each regional market brings an insight on the market share of the leading players. Additionally, the analysis highlights rise and fall in the market shares of the key players in the market.  

This report will help manufacturers, suppliers and distributors of the psoriasis therapeutics market to understand the present and future trends in this market and formulate their strategies accordingly.

1.  Preface          

1.1          Report Description

1.2          Research Methods

1.3          Research Approaches

 

2.  Executive Summary

 

3.  Global Psoriasis Therapeutics Market Overview                        

3.1          Introduction      

3.2          Market Dynamics            

                3.2.1      Drivers

                3.2.2      Restraints

                3.2.3      Opportunities

                3.2.4      Challenges

3.3          Porter’s Five Forces Analysis      

3.4          IGR – Growth Matrix Analysis    

3.5          Competitive Landscape in the Global Psoriasis therapeutics market          

 

4.  Global Psoriasis Therapeutics Market by Molecule 2017 - 2023           

4.1     Biologics   

4.2     Small Molecules     

 

5.  Global Psoriasis Therapeutics Market by Route of Administration 2017 - 2023             

5.1     Oral            

5.2     Parenteral               

5.3     Topical        

 

6.  Global Psoriasis Therapeutics Market by Dosage forms 2017 - 2023   

6.1     Solid          

6.2     Liquid        

6.3     Semi-solid                 

 

7.  Global Psoriasis Therapeutics Market by Mechanism of Action 2017 - 2023   

7.1      TNF Inhibitors       

7.2     PDE4 Inhibitors     

7.3     IL blocker

7.4     Others        

 

8.  Global Psoriasis Therapeutics Market by Regions 2017 - 2023              

8.1     Americas

                8.1.1    Americas Psoriasis Therapeutics Market by Molecule

                8.1.2    Americas Psoriasis Therapeutics Market by Route of administration

                8.1.3    Americas Psoriasis Therapeutics Market by Dosage forms

                8.1.4    Americas Psoriasis Therapeutics Market by Mechanism of Action

                8.1.5    Americas Psoriasis therapeutics Market by Country

               

8.2     Europe     

                8.2.1    Europe Psoriasis Therapeutics Market by Molecule

                8.2.2    Europe Psoriasis Therapeutics Market by Route of administration

                8.2.3    Europe Psoriasis Therapeutics Market by Dosage forms

                8.2.4    Europe Psoriasis Therapeutics Market by Mechanism of Action

                8.2.5    Europe Psoriasis Therapeutics Market by Country

               

8.3     Asia-Pacific             

                8.3.1    Asia-Pacific Psoriasis Therapeutics Market by Molecule

                8.3.2    Asia-Pacific Psoriasis Therapeutics Market by Route of administration

                8.3.3    Asia-Pacific Psoriasis Therapeutics Market by Dosage forms

                8.3.4    Asia-Pacific Psoriasis Therapeutics Market by Mechanism of Action

                8.3.5    Asia-Pacific Psoriasis Therapeutics Market by Country

               

8.4     RoW          

                8.4.1    RoW Psoriasis Therapeutics Market by Molecule

                8.4.2    RoW Psoriasis Therapeutics Market by Route of administration

                8.4.3    RoW Psoriasis Therapeutics Market by Dosage forms

                8.4.4    RoW Psoriasis Therapeutics Market by Mechanism of Action

                8.4.5    RoW Psoriasis therapeutics Market by Sub-region

 

9.  Companies Covered

9.1      Amgen, Inc.           

9.2     Johnson & Johnson             

9.3      Eli Lilly and Company         

9.4     AstraZeneca           

9.5     Novartis AG            

9.6     AbbVie Inc.             

9.7     Celgene Corporation          

9.8     Other companies in this market  


Got a Question?

If you have a question to ask our analyst, just fill this form and send it across, our representative will get in touch with you shortly.